Huizinga Robert Bindert

CIK 00018376481 companyVICTORIA, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001837648

Recent Transactions

19 trades

Award
Aurinia Pharmaceuticals Inc.$AUPH
Stock Option (right to buy)
2022-03-02+106,838→ 106,838 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2022-03-02$12.01/sh−4,849→ 69,379 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Restricted Stock Unit
2022-03-02+62,448→ 62,448 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2022-03-02+8,500→ 74,228 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Stock Option (right to buy)
2021-10-25−95,000→ 3,864 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-10-25$29.75/sh−130,000→ 65,728 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-10-25$3.20/sh+95,000→ 195,728 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-09-21$24.05/sh−27,136→ 106,092 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-09-21$23.66/sh−5,364→ 100,728 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-09-21$2.63/sh+16,000→ 122,092 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Stock Option (right to buy)
2021-09-21−11,136→ 98,864 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-09-21$3.20/sh+11,136→ 133,228 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Stock Option (right to buy)
2021-09-21−16,000→ 0 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-09-14$21.75/sh−22,500→ 106,092 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-09-10$19.83/sh−5,000→ 133,592 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-09-10$19.76/sh−5,000→ 128,592 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-09-07$18.30/sh−5,000→ 138,592 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2021-05-11$3.02/sh+40,000→ 143,592 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Stock Option (right to buy)
2021-05-11−40,000→ 0 total

Companies

Aurinia Pharmaceuticals Inc.
EVP of Research
$AUPH

Recent Filings

Address

#1203-4464 MARKHAM STREET

VICTORIA, A1, V8Z7X8

View on SEC.gov